skip to main content
covidend_logo_color

Our network of sites

Engaging working group

 
The COVID-19 Evidence Network to support Decision-making (COVID-END) has come together to help coordinate and reduce duplication in these remarkable efforts. Its initial focus includes supporting working groups to achieve and document quick-wins, and to establish processes to achieve and document longer-term wins, in seven areas including engaging those already supporting decision-makers to work in more coordinated and efficient ways.

Proposed terms of reference

  1. Identifying evidence groups that are contributing to the COVID-19 response and should be included in our communications (building from the list of rapid review centres developed by Laurenz Langer, etc.)
    1. Name
    2. Focus
    3. Taxonomy being used
    4. URL
    5. Email address
  2. Developing and communicating messages to these evidence groups about how to leverage existing evidence-related data (e.g., daily search data) and processes (e.g., PROSPERO registration)
    1. e.g., register all titles and protocols with PROSPERO (and possibly select other sites that follow similar ‘open synthesis’ principles)
    2. e.g., share an anticipated delivery date and update the date if conditions change
    3. e.g., upload completed reviews and guidelines to any of a small group of select sites that follow principles around transparency, etc.
  3. Canvassing input from these evidence groups for additional ideas for how to work more collaboratively as an evidence synthesis community, both within and across ‘divides’ (e.g., quantitative and qualitative synthesis, health and social sciences)
  4. Developing approaches to manually capturing reviews and guidelines that are not housed on portals being prioritized by the digitizing working group (e.g., biweekly website reviews)
  5. Identifying and engaging a broader array of groups (e.g., data analytics, modelling, implementation science, and monitoring and evaluation) that need to have access to the best evidence sources for their work
  6. Identifying and engaging a broader array of groups (e.g., horizon scanning / foresight and health technology assessment) that may be a source of insight about what evidence will be needed in future (possibly by building on work done by Anthrologica in relation to Ebola and its social impacts and/or by the Coalition for Epidemic Preparedness)

Participants

  1. Laurenz Langer, African Centre for Evidence, South Africa (co-chair)
  2. Maureen Dobbins, National Collaborating Centre for Methods and Tools, Canada (co-chair)
  3. Kamga Emmanuel Berinyuy, eBase, Cameroon
  4. Lesley Stewart, Centre for Research and Dissemination, PROSPERO, (University of York) UK
  5. Per-Olav Vandvik, Magic Evidence Ecosystem Foundation, Norway
  6. Sandy Oliver, EPPI Center UK
  7. Sylvia de Haan, Cochrane Collaboration, Switzerland
  8. Tamara Loutfi, Global Evidence Synthesis Initiative, Lebanon
  9. Secretariat: Francois-Pierre Gauvin, Heather Bullock, John Lavis and Safa Al-Khateeb, McMaster Health Forum | RISE, Canada

Meeting documents

Meeting date Documents
April 30, 2020
  1. Meeting notes

Familiarize yourself with our guide to key COVID-19 evidence sources to see how groups that already support decision-makers can work in more coordinated and efficient ways, which includes identifying what’s already out there that they can use or adapt and where there are gaps they need to fill.